{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:42:47Z","timestamp":1795117367391,"version":"4.10.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.cancergencyto.2009.04.013","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T09:41:04Z","timestamp":1249638064000},"page":"78-85","source":"Crossref","is-referenced-by-count":19,"title":["Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical\/pathologic features compared to \u20137\/del(7q) MDS"],"prefix":"10.1016","volume":"193","author":[{"given":"Marilyn L.","family":"Slovak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.04.013_bib1","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2003-01-0031","article-title":"Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10)","volume":"102","author":"Wang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib2","unstructured":"Huret JL. t(1;7)(q10;p10). Atlas of Genetics and Cytogenetics in Oncology and Haematology. Available at: http:\/\/www.AtlasGeneticsOncology.org\/Genes\/t0107ID1003.html. Accessed January 2009."},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/1097-0142(19900315)65:6<1350::AID-CNCR2820650617>3.0.CO;2-J","article-title":"The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication","volume":"65","author":"Horiike","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cancergencyto.2005.09.003","article-title":"Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10)","volume":"165","author":"Hsiao","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.leu.2404619","article-title":"Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms","volume":"21","author":"Sanada","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.leukres.2007.09.019","article-title":"Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms","volume":"32","author":"So","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib8","series-title":"An International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2005"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib9","series-title":"World Health Organization of Tumors of Haematopoietic and Lymphoid Tissues. The Myelodysplastic Syndromes\/Neoplasms. Chapter 5","first-page":"87","year":"2009"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2004-02-0754","article-title":"Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation","volume":"104","author":"Christiansen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib13","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2003-09-3074","article-title":"High incidence of somatic mutations in the AML1\/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia","volume":"103","author":"Harada","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.leu.2402766","article-title":"New mechanisms of AML1 gene alteration in hematological malignancies","volume":"17","author":"Roumier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/sj.leu.2404009","article-title":"Mutations of genes in the receptor tyrosine kinase (RTK)\/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia","volume":"19","author":"Christiansen","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.1995.tb03405.x","article-title":"Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study","volume":"90","author":"Ma","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1365-2141.1996.d01-1961.x","article-title":"Clonal involvement of eosinophils in therapy-related myelodysplastic syndrome with eosinophilia, translocation t(1;7) and lung cancer","volume":"95","author":"Imai","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-4608(98)00055-7","article-title":"Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): confirmation of eosinophil clonal involvement by fluorescence in situ hybridization","volume":"107","author":"Forrest","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.leu.2403806","article-title":"Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution","volume":"19","author":"Bernasconi","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib20","first-page":"1168","article-title":"Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes","volume":"90","author":"Sole","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib21","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","article-title":"Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities","volume":"113","author":"Pozdnyakova","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-4608(01)00533-7","article-title":"Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study","volume":"132","author":"Lee","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cancergencyto.2006.10.013","article-title":"Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies","volume":"173","author":"Adeyinka","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cancergencyto.2008.05.003","article-title":"Pattern of trisomy 1q in hematological malignancies: a single institution experience","volume":"186","author":"Djordjevic","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib25","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib26","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2007-03-079673","article-title":"Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes","volume":"110","author":"Mohamedali","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2007-05-092304","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD, and MDS-derived AML","volume":"111","author":"Gondek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3324\/haematol.12603","article-title":"Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays","volume":"93","author":"Wang","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.04.013_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2141.2008.07245.x","article-title":"Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review","volume":"142","author":"Bernasconi","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809002337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809002337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T08:08:32Z","timestamp":1590048512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809002337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0165460809002337"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.04.013","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}